Trivalent influenza vaccine (National Cancer Institute)

三价流感疫苗（National Cancer Institute）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTrivalent influenza vaccine (National Cancer Institute)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Cancer Institute

China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A